Schizophrenia related gene and protein
CA 2418779 A1 · Owner: Bougueleret, Lydie · Inventors: Bougueleret, Lydie; Bihain, Bernard; Bour, Barbara
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to polynucleotides of the PAPAP gene polypeptides , encoded by the PAPAP gene and antibodies directed specifically against such polypeptides. The invention also concerns methods for the treatment or diagnosis of schizophrenia, bipolar disorder or related CNS disorder. The invention also concerns the interaction of PAPAP with schizophrenia candidate gene g34872.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 26, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 26, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 26, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.